231 related articles for article (PubMed ID: 11684638)
1. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.
Campbell AI; Zhao Y; Sandhu R; Stewart DJ
Circulation; 2001 Oct; 104(18):2242-8. PubMed ID: 11684638
[TBL] [Abstract][Full Text] [Related]
2. Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer.
Zhao YD; Courtman DW; Ng DS; Robb MJ; Deng YP; Trogadis J; Han RN; Stewart DJ
Am J Respir Cell Mol Biol; 2006 Aug; 35(2):182-9. PubMed ID: 16543611
[TBL] [Abstract][Full Text] [Related]
3. Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension.
Campbell AI; Kuliszewski MA; Stewart DJ
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):567-75. PubMed ID: 10536116
[TBL] [Abstract][Full Text] [Related]
4. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
[TBL] [Abstract][Full Text] [Related]
5. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
Partovian C; Adnot S; Eddahibi S; Teiger E; Levame M; Dreyfus P; Raffestin B; Frelin C
Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
[TBL] [Abstract][Full Text] [Related]
6. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
7. Protective role of angiopoietin-1 in experimental pulmonary hypertension.
Zhao YD; Campbell AI; Robb M; Ng D; Stewart DJ
Circ Res; 2003 May; 92(9):984-91. PubMed ID: 12690034
[TBL] [Abstract][Full Text] [Related]
8. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone.
Klekamp JG; Jarzecka K; Hoover RL; Summar ML; Redmond N; Perkett EA
Pediatr Res; 1997 Dec; 42(6):744-9. PubMed ID: 9396552
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
Hadri L; Kratlian RG; Benard L; Maron BA; Dorfmüller P; Ladage D; Guignabert C; Ishikawa K; Aguero J; Ibanez B; Turnbull IC; Kohlbrenner E; Liang L; Zsebo K; Humbert M; Hulot JS; Kawase Y; Hajjar RJ; Leopold JA
Circulation; 2013 Jul; 128(5):512-23. PubMed ID: 23804254
[TBL] [Abstract][Full Text] [Related]
11. Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
Tahara N; Kai H; Niiyama H; Mori T; Sugi Y; Takayama N; Yasukawa H; Numaguchi Y; Matsui H; Okumura K; Imaizumi T
Hum Gene Ther; 2004 Dec; 15(12):1270-8. PubMed ID: 15684702
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
Partovian C; Adnot S; Raffestin B; Louzier V; Levame M; Mavier IM; Lemarchand P; Eddahibi S
Am J Respir Cell Mol Biol; 2000 Dec; 23(6):762-71. PubMed ID: 11104729
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.
Baber SR; Deng W; Master RG; Bunnell BA; Taylor BK; Murthy SN; Hyman AL; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1120-8. PubMed ID: 16980338
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Dulak J; Józkowicz A; Guevara I; Dembińska-Kieć A
Pol J Pharmacol; 1999; 51(3):233-41. PubMed ID: 10600037
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus.
Grover TR; Parker TA; Zenge JP; Markham NE; Kinsella JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L508-17. PubMed ID: 12573989
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression.
Fujita M; Mason RJ; Cool C; Shannon JM; Hara N; Fagan KA
J Appl Physiol (1985); 2002 Dec; 93(6):2162-70. PubMed ID: 12391106
[TBL] [Abstract][Full Text] [Related]
19. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells.
Nagaya N; Kangawa K; Kanda M; Uematsu M; Horio T; Fukuyama N; Hino J; Harada-Shiba M; Okumura H; Tabata Y; Mochizuki N; Chiba Y; Nishioka K; Miyatake K; Asahara T; Hara H; Mori H
Circulation; 2003 Aug; 108(7):889-95. PubMed ID: 12835224
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve.
Rajagopalan S; Shah M; Luciano A; Crystal R; Nabel EG
Circulation; 2001 Aug; 104(7):753-5. PubMed ID: 11502697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
